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Background: Defects in airway mucosal defense, including decreased mucus clearance, contribute to the pathogenesis
of human chronic obstructive pulmonary diseases. Scnn1b-Tg mice, which exhibit chronic airway surface dehydration
from birth, can be used as a model to study the pathogenesis of muco-obstructive lung disease across developmental
stages. To identify molecular signatures associated with obstructive lung disease in this model, gene expression analyses
were performed on whole lung and purified lung macrophages collected from Scnn1b-Tg and wild-type (WT) littermates
at four pathologically relevant time points. Macrophage gene expression at 6 weeks was evaluated in mice from a
germ-free environment to understand the contribution of microbes to disease development.
Results: Development- and disease-specific shifts in gene expression related to Scnn1b over-expression were revealed
in longitudinal analyses. While the total number of transgene-related differentially expressed genes producing robust
signals was relatively small in whole lung (n = 84), Gene Set Enrichment Analysis (GSEA) revealed significantly perturbed
biological pathways and interactions between normal lung development and disease initiation/progression. Purified
lung macrophages from Scnn1b-Tg mice exhibited numerous robust and dynamic gene expression changes. The
expression levels of Classically-activated (M1) macrophage signatures were significantly altered at post-natal day
(PND) 3 when Scnn1b-Tg mice lung exhibit spontaneous bacterial infections, while alternatively-activated (M2)
macrophage signatures were more prominent by PND 42, producing a mixed M1-M2 activation profile. While
differentially-regulated, inflammation-related genes were consistently identified in both tissues in Scnn1b-Tg mice, there
was little overlap between tissues or across time, highlighting time- and tissue-specific responses. Macrophages purified
from adult germ-free Scnn1b-Tg mice exhibited signatures remarkably similar to non-germ-free counterparts, indicating
that the late-phase macrophage activation profile was not microbe-dependent.
Conclusions: Whole lung and pulmonary macrophages respond independently and dynamically to local stresses
associated with airway mucus stasis. Disease-specific responses interact with normal developmental processes,
influencing the final state of disease in this model. The robust signatures observed in Scnn1b-Tg lung macrophages
highlight their critical role in disease pathogenesis. These studies emphasize the importance of region-, cell-type-, and
time-dependent analyses to fully dissect the natural history of disease and the consequences of disease on normal lung
development.
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Defects in mucus clearance are characteristic of muco-
obstructive pulmonary diseases of genetic or environmental
origins, e.g., cystic fibrosis (CF), primary ciliary dyskinesia
(PCD), and the chronic bronchitic (CB) form of chronic
obstructive pulmonary disease (COPD) [1]. Airway mucus
clearance is a multifactorial process, integrating epithelial
mucin secretion and airway surface hydration with ciliary
beat, cough, and/or gas–liquid pumping [2,3]. While
airway remodeling and inflammation often accompany
defective mucus clearance [1,4], the mechanisms linking
defective mucus clearance to obstructive lung disease
are poorly understood. One paradigm is that defects in
mucus clearance produce static mucus that provide a
nidus for microbial colonization and resultant inflam-
matory responses [5]. While this concept is supported
by the presence of pathogens in lungs of patients exhi-
biting defects in mucus clearance [6-8], the roles of the
primary defects (airway surface liquid dehydration,
dehydrated/concentrated mucus, lack of ciliary beat,
decreased mucus clearance) in establishment of chronic
inflammation are not fully appreciated. Additional com-
plexity arises when the consequences of mucus obstruction
are considered in the context of normal lung development
and aging, i.e., mucus obstruction early in life (CF, PCD)
may generate long-term effects that would not occur if the
obstruction occurs later (CB, COPD).
To model defective airway mucus clearance in vivo,
transgenic mice over-expressing the epithelial sodium
channel beta subunit [βENaC, encoded by the Scnn1b
(Sodium channel non-voltage-gated 1, beta subunit) gene]
in airway club cells (previously referred to as Clara cells,
or known as CC10-expressing secretory cells) were
generated [9]. The initiating pathophysiological defect
in these mice, i.e., airway surface liquid (ASL) depletion,
produces mucus dehydration, reduced mucus clearance,
and overt pulmonary disease characterized by airway
mucus obstruction, inflammation, and spontaneous bac-
terial infection [9-13]. At birth, the lungs of Scnn1b trans-
genic (Scnn1b-Tg) mice are histologically normal. During
the early neonatal period, i.e., post-natal day (PND) 3–10,
significant tracheal mucus plugs develop that are associ-
ated with neonatal mortality and distal airway hypoxia
[10-12]. Transient necrotic degeneration of intrapulmon-
ary club cells is also observed around PND 3 [12]. Macro-
phage activation, neutrophilia, and bacterial infection are
detected as early as PND 5 [13]. Importantly, because
murine lungs continue to mature during early post-natal
life [14], the disease processes from PND 3–10 are occur-
ring during periods of active lung development, which has
relevance for lung diseases such as bronchopulmonary
dysplasia (BPD) and early childhood exposures to toxic
or infectious agents, i.e., smoke or viral infections,
where inflammatory processes and development intersectto produce long-term, negative consequences for lung
function [15-18]. After PND 10, mucus obstruction be-
comes more prominent in the main stem bronchi of the
Scnn1b-Tg mice, airway inflammation becomes more
modest, bacterial infection is intermittent, yet broncho-
alveolar lavage (BAL) mucin content and mucin gene
transcription remain elevated [12,19]. Further, alveolar
air space enlargement becomes clearly evident, and the
incidence of bronchus associated lymphoid tissue (BALT)
increases [10,13].
Pulmonary macrophages carry out important gate-
keeping roles in host defense [20]. As resident innate
immune cells, they must remain quiescent in the healthy
state, yet they must be able to respond when lung homeo-
stasis is threatened. In health and disease, crosstalk occurs
between the airway epithelium and macrophages via either
receptor-mediated cellular interactions [21] or through
humoral signals released by either cell types [22]. The
airway epithelium is the epicenter of disease initiation in
the Scnn1b-Tg mice, and macrophages are strategically
positioned to respond to defects in airway clearance. A
consistent feature of disease in the Scnn1b-Tg mice is the
presence of morphologically activated pulmonary macro-
phages [13]. Macrophages are morphologically activated
early (by 3 days of age), and previous work identified up-
regulation of genes associated with macrophage activation,
including chitinases, IL-13, and other cytokines [12].
Macrophage-derived protease, Mmp12, is critical for
the development of the emphysema in Scnn1b-Tg mice
[23]. Germ-free Scnn1b-Tg mice exhibit lung pathology,
including morphological activation of macrophages, very
similar to Scnn1b-Tg mice raised in specific pathogen free
(SPF) conditions, indicating that the macrophages respond
directly to the primary defect of airway surface dehydra-
tion and mucus stasis [13].
Genetic and pharmacologic studies suggest activation
of multiple signaling pathways in response to defective
mucus clearance in the Scnn1b-Tg mice. For example,
genetic disruption of major pathways conventionally as-
sociated with airway inflammation and remodeling, e.g.,
MyD88 and IL-4Rα, did not dramatically alter disease
development [13,24], highlighting the need to explore
additional disease-promoting pathways. In the present
study, we hypothesized that disease-associated molecular
signatures linked to key host response, e.g., airway inflam-
mation and mucus cell metaplasia, could be identified
by evaluating gene expression in selected tissues from
Scnn1b-Tg mice at critical time points. Accordingly, we
selected the following time points: 1) immediately after
birth (PND 0, i.e., <24 hours), when the transgene is
overexpressed but disease is not yet manifested histo-
logically; 2) at PND 3, when tracheal mucus obstruction
is prominent; 3) at PND 10, when chronic lower respira-
tory disease is being initiated; and 4) at PND 42, after
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and pathways analyses were used to generate a picture
of differential gene expression in whole lung and macro-
phages. The results highlight a highly dynamic interplay
of tissue-specific and time-dependent responses and set
the stage for future studies to explore these complex
interactions.
Methods
Mice and animal husbandry
Congenic C57BL/6N Scnn1b-Tg mice and WT littermates
were maintained in a specific pathogen free (SPF) animal
facility [10]. Germ-free (GF) mice were maintained in the
National Gnotobiotic Rodent Resource Center at UNC
[13]. Animals used in this study were maintained and
studied under protocols approved by the University of
North Carolina Institutional Animal Care and Use
Committee.
Lung RNA isolation
Tissues were collected from male mice at a designated
time (1:00 pm). The lung left lobe was removed by cutting
the extrapulmonary bronchus at the level of the hilum.
Dissected tissue was stored in RNAzol (QIAzol lysis re-
agent, Qiagen Sciences, Valencia, CA) at −20°C. RNA was
prepared using Qiagen RNeasy Mini Kit (Qiagen Sciences,
Valencia, CA; following protocol recommended for animal
tissue) followed by ammonium acetate precipitation.
To minimize the effect of biological variation between
individual animals, total RNA from three age- and
genotype-matched mice were pooled to constitute each
sample. A total of three RNA samples were analyzed at
each time point for WT and Scnn1b-Tg mice.
Macrophage RNA preparation
Male Scnn1b-Tg mice and WT littermates were anes-
thetized with an intraperitoneal administration of 2,2,2
tribromoethanol (T48402, Sigma, St. Louis, MO). The
lungs were lavaged at least 4 times with calcium- and
magnesium-free DPBS supplemented with 0.5 mM
EDTA with the volume determined on weight-based
formula [13]. Magnetic-activated cell sorting (MACS) was
used to purify macrophages using Anti-Ly-6G MicroBead
Kit (130-092-332, Miltenyi Biotech, MA). This approach
selectively deplete granulocytes that predominantly express
Ly-6G as a surface marker [25]. Since BAL cells include
granulocytes, macrophages, lymphocytes and occasional
dendritic and epithelial cells, the Ly-6G negative frac-
tion, in addition to macrophages, is expected to include
lymphocytes, dendritic cells and epithelial cells, but these
cells are rare in these preparations. BALs cell pellets were
suspended in 200 μl of MACS buffer. 50 μl of anti-Ly-6G-
Biotin solution was added followed by incubation at 4°C
for 10 min. Subsequently, 100 μl of anti-biotin microbeadsand 150 μl of MACS buffer were added followed by incu-
bation at 4°C for 15 minutes. Cell pellets washed with
10 ml MACS buffer were dissolved in 500 μl of MACS
buffer. Thereafter, macrophage isolation through negative
selection was carried out according to manufacturer’s
recommendations. Ly-6G negative cells (predominantly
macrophages) were pelleted, snap-frozen, and stored
at −80°C. At PND 0, PND 3 and PND 10 time points, total
macrophages collected from three genotype-matched
pups were pooled to generate each sample. Each sam-
ple at PND 42 time point represents macrophages
collected from individual mice. Frozen macrophage
pellets were lysed and homogenized in lysis buffer and
QIAshredder (Qiagen, Valencia, CA). Genomic DNA
was eliminated using gDNA eliminator spin columns
(Qiagen, Valencia, CA). The RNA was isolated using
Purelink RNA mini kit (Invitrogen, NY).
cDNA generation and microarray
12 ng RNA was used to generate cDNA using Ovation
Pico WTA system V2 kit (NuGEN Technologies, CA).
Total RNA or cDNA samples were submitted to the
UNC Functional Genomics Core for cDNA preparation
and hybridized to Affymetrix Mouse Gene 1.0 ST arrays
according to the manufacturer’s instructions (Affymetrix
Inc., Santa Clara, CA).
Microarray data analysis
Probe level intensities from Affymetrix GeneChip Scanner
3000 in .CEL files were evaluated for quality by whole
array statistics using Affymetrix Expression Console
software. Gene expression analyses were performed
using Partek Genomics Suite v6.6 (Partek Inc., St. Louis,
MO). Briefly, probeset intensities were extracted from
.CEL files by RMA background correction following GC
content and sequence adjustments, normalized using
quantile normalization, and gene level intensities were
summarized through median polish, based on a modi-
fied meta-probeset mapping (.mps) derived from Affy-
metrix latest transcript annotation (release na33.2 mm9).
The meta-probeset mapping consolidated all probesets to
unique gene identifiers parsed from Affymetrix transcript
annotation with the following precedence: ENSEMBL
gene, Refseq mRNA, and Genbank nucleotide identi-
fiers. Data quality, batch effect, and sample groupings
were assessed by Principle Component Analysis (PCA)
with correlation dispersion matrices. Differential gene
expression was analyzed using ANOVA and linear con-
trast between experimental groups. The resultant differen-
tial expression (DE) p-values were adjusted for Multiple
Test Correction using the False Discovery Rate (FDR) by
Benjamini-Hochberg method [26].
Differentially expressed genes (DEG) were obtained
through the combination of selected p-value and fold
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malized log2 intensities from individual arrays of DEGs
were extracted for hierarchical clustering. Normalized
log2 intensities were used in Gene Set Enrichment
Analyses (GSEA) against gene sets derived from Biological
Processes of the current Gene Ontology (GO) annotation
database and custom gene sets relevant to lung disease
and cellular physiology. Visual representations of GSEA
enrichment FDR q-values from multiple sample groups
were generated by hierarchical clustering of the trans-
formed q-values using Cluster3 [27] and Java TreeView
[28]. Detailed data mining of GSEA results from related
GO vocabulary terms was performed by extracting
relationships between functional terms from the current
GO flat file download, and visualizing the resultant
networks decorated by specific enrichment FDR q-
values with Cytoscape [29]. The complete expression
dataset has been submitted to the Gene Expression
Omnibus (GEO) database with the accession number of
GSE47551. http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE47551.
Protein extraction and western blotting
Total protein was extracted from BAL macrophages
after lysing with Radioimmuno Precipitation Assay buf-
fer supplemented with 0.5 mM EDTA, 0.1 mM DDT
and Halt protease inhibitors (Thermoscientific, Rockford,
IL). Proteins were separated by SDS-PAGE (NuPage
4-12% Bis-Tris gradient gel) using MES buffer (Invitrogen,
CA) and transferred to PVDF membranes. Rabbit
antibodies against FIZZ-1 (39626, ABCAM), YM1/2
(a kind gift from Dr. Shioko Kimura, NCI, Maryland),
and α-tubulin (T5168, Sigma) were used for the
westerns. Protein bands were analyzed using Alexa fluor
680 Goat anti-rabbit IgG (A21109, Invitrogen) or IRdye800
anti-mouse IgG (610-132-121, Rockland). Quantification
was performed using Odyssey and the data was normal-
ized to α-tubulin. The data analysis was performed using
unpaired two-tailed t-test on Graph-Pad Prism (La
Jolla, CA).
Results and discussion
Whole lung gene expression patterns are altered by
developmental age and Scnn1b-Tg expression
Principal Components Analysis (PCA) revealed that age
was the primary factor affecting global gene expression
in lung specimens (Figure 1a). PC1 (36.5% of over all
variance) separated PND 0 mice from older animals,
while PC2 (19.9% of overall variance) separated PND 3
and 10 from PND 42. Scnn1b-Tg mice clustered tightly
with their WT littermates at all ages. By extending the
analysis to evaluate PC4 and PC5, the WT mice began
to separate from Scnn1b-Tg mice, but only at PND 10
and PND 42, respectively (Additional file 1: Figure S1a).This pattern was also observed upon hierarchical
clustering of a combined set of 4514 differentially
expressed genes (DEGs; FDR ≤ 0.05, FC ≥ 2) comparing
PND 0 expression values to all other time points for
each genotype (Figure 1b; Additional file 2: Results file
S1). The heat-map demonstrates that a majority of
changes in global gene expression (mainly down-
regulation) occurred between PND 0 and PND 3, regard-
less of genotype.
As predicted from the PCA and the hierarchical clus-
tering heat maps, robust differences in gene expression
were present in both WT (Table 1) and Scnn1b-Tg
(Table 2) mice across development, and the DEGs were
qualitatively different among time intervals, consistent
with the published reports highlighting the continual
postnatal lung development [14] and gene expression
profiling of developing murine lungs [30]. The top
DEGs up-regulated from PND 0 to PND 3 in WT
(Table 1) as well as Scnn1b-Tg (Table 2) mice were
largely non-coding RNA species including long, non-
coding RNAs and miRNAs. Non-coding RNAs tended
to be robustly down-regulated between PND 3 to PND
10. While the specific functions of non-coding RNAs
are only now being evaluated, their hypothesized role as
master regulators of cell development controlling tran-
scriptional regulatory circuitry is consistent with this
finding [31,32].
Interestingly, many of the top up-regulated genes from
PND 3 to PND 10 in both WT and Scnn1b-Tg mice are
related to goblet cell (mucous cell) function and are fre-
quently associated with Th2 inflammation in mice (Clca3,
Chi3l4, Chi3l3, Muc5ac, Muc5b, Tff2) (Tables 1 and 2)
[9,33,34]. This finding is consistent with the overall Th2
polarization characteristic of early postnatal immunity
[35,36] and parallels the wave of goblet cell appearance
observed histologically during this time frame [10]. We
speculate that these under-appreciated responses observed
in developing lung are related to innate defense functions
of mucus/mucus clearance during the early neonatal
period. The fold-increase for this group of genes was al-
ways less in Scnn1b-Tg compared to WT during the PND
3–10 interval. Interestingly, while these genes were later
down-regulated in WT mice during the PND 10–42 inter-
val, they continued to be up-regulated further at the
later interval in Scnn1b-Tg mice (Tables 1 and 2 and data
not shown). Thus, failure to down-regulate these Th2
response-associated genes, e.g., Clca3, Chi3l3, and Chi3l4,
in the PND 10–42 interval is a key developmental shift
that occurs as a consequence of Scnn1b-Tg expression.
Also notable during the PND 3 to PND 10 interval was a
large up-regulation of Mmp12 in Scnn1b-Tg mice as com-
pared to WT (Table 2), consistent with the role of Mmp12
as a contributor to the airspace enlargement in this model
[23].
a c
b
Figure 1 Gene expression patterns in WT and Scnn1b-Tg whole lung. (a) Principal component analysis (PCA) of gene expression from WT
and Scnn1b-Tg whole lungs at PND 0, 3, 10, and 42 plotted in two-dimensional space using the first two principal components, which together
constitute 55.4% of the overall variance in this study. Squares = WT; Triangles = Scnn1b-Tg. Each symbol represents the results of a single microarray.
Each symbol represents a pool of animals as described in the methods. N = 3 pools for each age and genotype. Age is designated by color: PND 0
(red), PND 3 (green), PND 10 (blue), and PND 42 (purple). (b) Unsupervised hierarchical clustering of the combined set of differentially expressed genes
(DEGs) that survive the filtering criteria (FDR ≤ 0.05, fold-change ≥ 2) across development (comparing PND 0 to all other time points for each genotype,
i.e., WT and Scnn1b-Tg; total genes represented = 4514; Additional file 2: Results file S1). Dark blue indicates lower expression levels and bright
red indicates higher expression levels, and each column represents the results of one microarray N = 3 for each genotype at each age). (c) Pie charts
highlighting the shift in expression of developmentally regulated genes due to Scnn1b-Tg expression. Each row represents a different developmental
interval and each pie chart represents the pattern for the genes that are differentially regulated (fold-change >2.0; FDR < 0.05) in WT mice. Genes
normally up-regulated in WT mice are represented in the left column and genes normally down-regulated are represented in the right column, with
the number of gene shown for each piechart. The percentages represent the genes that are either higher or lower (blue and red, respectively) in WT
vs Scnn1b-Tg at the later developmental stage represented by the interval.
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was informative, interpretation of collective expression
patterns was aided by Gene Set Enrichment Analysis
(GSEA), which identified the top Gene Ontology groups
that differed across developmental intervals (Table 3).
GSEA analysis revealed that G-protein regulated signaling
pathways capable of responding to various stimuli are
established early in post-natal development (PND 3 versusPND 0) for both WT and Scnn1b-Tg mice (Table 3). Up-
and down-regulated pathways were more similar between
the two genotypes at the early (PND 3 versus PND 0) and
late (PND 42 versus PND 10) intervals compared to the
intermediate PND 10 versus PND 3 interval. The patterns
observed in WT mice for the PND 3 to PND 10 interval
suggest continued lung development based upon the up-
regulation of pathways involved with reorganization of the
Table 1 Developmentally regulated genes in whole lung from WT mice
Gene
Name
Fold change: PND 3 vs 0 Gene
Name
Fold change: PND 10 vs 3 Gene
Name
Fold change: PND 42 vs 10
WT Scnn1b-Tg WT Scnn1b-Tg WT Scnn1b-Tg
UP-REGULATED
Vaultrc5* 28.5 27.7 Clca3 71.5 12.0 Snord116* 26.2 19.6
Gm22866* 24.4 26.8 Chi3l4 12.9 4.6 Gm10722 25.7 43.9
Snora16a* 20.3 22.0 Chi3l3 10.1 5.2 Bpifa1 23.0 7.3
Rnu3a* 18.4 16.6 Crabp1 8.9 5.6 Inmt 17.8 10.8
Gm26493 17.3 13.2 Tff2 8.0 7.9 Cyp2b10 17.6 10.1
Rnu3b1* 15.7 14.7 Ltbp2 6.8 3.9 Gm10800 17.6 67.7
Gm23444 13.8 13.3 Hmcn1 5.4 3.3 Fmo3 14.9 6.6
Snord22* 13.7 13.4 C7 5.4 7.4 Lrat 14.7 14.7
Snora69* 13.3 11.9 Bpifb1 4.2 3.1 Cfd 13.9 14.4
Rny1* 13.1 15.6 Enpp1 4.0 1.9 Nr1d1 13.7 14.4
n-R5s25* 12.4 13.7 Muc5ac 4.0 1.5 C4b 13.2 13.8
Snora23* 12.4 10.5 Tnc 3.9 3.0 Gm25089* 11.8 9.5
Snord118* 11.1 7.2 A2m 3.7 2.1 Prelp 11.6 11.6
Gm24616 10.9 8.4 Muc5b 3.7 2.0 Serpina3n 11.3 6.3
Gm23927 10.0 13.5 Mir27b* 3.6 1.7 Mir680-2* 11.2 9.0
DOWN-REGULATED
Meg3* −32.1 −34.3 Gm26493 −12.9 −16 Tnc −25.1 −10
C530030P08Rik −10.3 −19 Snora69* −9.8 −9.6 Egfem1 −24 −18
Zbtb16 −8.8 −3.3 Gm24616 −8.8 −12.2 Prss35 −18.4 −9.2
Malat1* −8.8 −9.7 Snord118* −7.6 −4.7 Agt −14.8 −9.3
6720401G13Rik* −7.9 −11.7 Snora34* −5.1 −6 Vcan −14.4 −7.5
Mir145 −6.2 −11.9 Olfm4 −4.8 −3.9 Spon2 −12.7 −7.6
Atp6v0a4 −6.2 −2.2 Asprv1 −4.6 −1.8 Slc27a6 −12.7 −12.6
Adamtsl2 −6 −3 Cldn4 −4.5 −3.5 Frem1 −12.3 −6.4
Wnk1 −5.8 −9 Stfa3 −4.2 −3.4 Clca3 −11 11.6
Dlk1 −5.8 −4.1 H19* −4.1 −1.5 6330403K07Rik* −10.1 −4.8
Tead1 −5.7 −5.6 Igf2 −4 −3.1 Ccna2 −9.9 −7.8
Nfat5 −5.6 −7.6 Agtr2 −3.6 −3.2 Crabp1 −9.7 −4.8
Cox20 −5.5 −7.9 S100a14 −3.4 −3.9 Stfa2l1 −9.5 −8.7
Tfcp2l1 −5.3 −3.9 Gdpd2 −3.2 −2.6 Phex −9.2 −5.5
Leng8 −5.2 −7.1 Smpx −3.2 −1.3 Chi3l4 −8.9 10.5
Listing of the top 15 developmentally up- and down-regulated genes from whole lung of WT mice between three separate age intervals. The fold-changes for
these top 15 genes are shown for both the WT and the Scnn1b-Tg mice.
* Non-coding RNA species.
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maturation of vessels. During the same interval, down-
regulation of pathways involved in defense and killing of
pathogens suggests the establishment of immune homeo-
stasis in WT mice. Significant development of an adaptive
immune response signature occurred during the PND 10
and PND 42 interval in both lines of mice as indicated by
up-regulation of GO pathways involving humoral immune
responses, lymphocyte immunity, antigen processing, and
complement activation.Scnn1b-Tg mice showed early evidence of inflammatory
signaling during the PND 0 to PND 3 interval as indicated
by up-regulation of GO inflammatory response and
cytokine signaling pathways (Table 3). Up-regulated
GO groups related to mitosis at the PND3 to PND 10
interval in Scnn1b-Tg mice point to transgene
expression-induced shifts in the mitotic state of the
lung. Furthermore, the down-regulation of GO immune
defense pathways seen in WT mice during the PND 3 to
PND 10 interval was clearly disrupted in the Scnn1b-Tg
Table 2 Developmentally regulated genes in whole lung from Scnn1b-Tg mice
Gene
Name
Fold change: PND 3 vs 0 Gene
Name
Fold change: PND 10 vs 3 Gene
Name
Fold change: PND 42 vs 10
Scnn1b-Tg WT Scnn1b-Tg WT Scnn1b-Tg WT
UP-REGULATED
Vaultrc5* 27.7 28.4 Clca3 12.0 71.4 Gm10800 67.8 17.6
Gm22866* 26.8 24.4 Mmp12 11.5 1.9 Gm10722 43.9 25.8
Snora16a* 22.0 20.3 Tff2 7.9 8.0 Snord116* 19.6 26.2
Rnu3a* 16.6 18.4 C7 7.4 5.4 Lrat 14.7 14.8
Rny1* 15.6 13.1 Crabp1 5.7 8.9 Nr1d1 14.4 13.8
Rnu3b1* 14.7 15.7 Chi3l3 5.2 10.1 Cfd 14.4 13.9
n-R5s25* 13.6 12.4 Chi3l4 4.6 13.0 C4b 13.8 13.2
Gm23927* 13.5 10.0 H2-Aa 4.6 2.6 Chi3l3 12.2 1.4
Snord22* 13.4 13.7 H2-Ab1 4.3 2.8 Car3 11.9 10.6
Gm23444 13.3 13.9 Ltbp2 3.9 6.8 Prelp 11.6 11.6
Gm26493 13.2 17.3 4833424O15Rik 3.8 2.7 Clca3 11.6 −10.9
Snora69* 11.9 13.3 Cd74 3.7 2.3 Inmt 10.8 17.8
Snora23* 10.5 12.4 H2-Eb1 3.7 2.6 Chi3l4 10.5 −8.9
Snord35b* 9.6 7.9 Aard 3.6 1.9 Cxcl14 10.2 8.0
Snora34* 9.3 9.6 Cdkn2c 3.4 3.3 Speer8-ps1 10.2 8.7
DOWN-REGULATED
Meg3* −34.3 −32.1 Gm26493* −16.0 −12.3 Egfem1 −18.0 −24.0
C530030P08Rik −19.0 −10.3 Gm24616* −12.2 −8.8 H19* −13.9 −5.5
Mir145* −11.9 −6.2 Snora69* −9.6 −9.8 Slc27a6 −12.6 −12.7
6720401G13Rik −11.7 −7.9 Snora23* −9.4 −5.5 Tnc −10.0 −25.1
Malat1* −9.7 −8.8 Snora34* −6.0 −5.1 Capn6 −9.8 −7.6
Gm7265 −9.5 −4.5 Gm10722 −4.7 −1.7 Agt −9.3 −14.8
Wnk1 −9.0 −5.8 S100a14 −3.9 −3.4 Prss35 −9.2 −18.4
Mir23b* −8.6 −5.1 Gm22806* −3.6 −3.1 Pbk −8.8 −3.7
Cox20 −7.9 −5.5 Rnu1b1* −3.6 −2.4 Stfa2l1 −8.7 −9.5
Nfat5 −7.6 −5.6 Cldn4 −3.5 −4.5 Hist1h2ab −8.6 −7.3
Gm25831* −7.2 −2.6 Agtr2 −3.2 −3.6 Nuf2 −8.3 −5.6
Leng8 −7.1 −5.2 Igf2 −3.1 −4.0 Ccnb2 −7.9 −5.6
Fbxl7 −5.9 −3.4 Upk3a −3.1 −2.4 Ccna2 −7.8 −9.9
B930095G15Rik −5.7 −3.7 Cst8 −2.8 −2.3 Spon2 −7.6 −12.7
Srrm2 −5.7 −4.2 Liph −2.7 −1.9 Vcan −7.5 −14.4
Top 15 developmentally up- and down-regulated genes from whole lung of Scnn1b-Tg mice between three separate age intervals. The fold-changes for these top
15 genes are shown for both Scnn1b-Tg and the WT mice.
* Non-coding RNA species.
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http://www.biomedcentral.com/1471-2164/15/726line. Indeed, closer evaluation identified a pattern whereby
expression of the transgene altered normal developmental
processes in subtle, but measureable, ways that were not
immediately apparent (Figure 1c). The absolute expres-
sion level of developmentally up-regulated genes was
consistently less in the Scnn1b-Tg mice compared to
WT, and at PND 10, a striking 97% of these genes had
lower expression in Scnn1b-Tg mice compared to WT
(Figure 1c). An inverse phenomenon held true for genes
that were developmentally down-regulated in WT mice,which trended towards higher expression in Scnn1b-Tg
mice. While the fold-changes between Scnn1b-Tg and
WT for these genes were generally subtle, the consistency
of the pattern leads to the conclusion that expression of
the transgene, and/or its resultant pathology, alters devel-
opmental pathways. The presence of an inflammatory
stimulus in the context of developing lung tissue during
this early post-natal timeframe in this model is highly rele-
vant to human bronchopulmonary dysplasia (BPD),
whereby the under-developed lungs of premature infants
Table 3 Developmentally regulated Gene Ontology groups for whole lung in WT and Scnn1b-Tg mice
PND 3 versus PND 0 PND 10 versus PND3 PND 42 versus PND 10
WT Scnn1b-Tg WT Scnn1b-Tg WT Scnn1b-Tg
UP-REGULATED
GO:0007608 GO:0007608 GO:0030198 GO:0007067 GO:0006959 GO:0006959
Sensory perception
of smell
Sensory perception
of smell
Extracellular matrix
organization
Mitosis Humoral immune
response
Humoral immune
response
GO:0007606 GO:0007606 GO:0043062 GO:0000280 GO:0048002 GO:0019882
Sensory perception
of chemical stimulus
Sensory perception
of chemical stimulus
Extracellular structure
organization
Nuclear division Antigen processing and
presentation of peptide
antigen
Antigen processing and
presentation
GO:0007600 GO:0007600 GO:0021988 GO:0007059 GO:0002455 GO:0002253
Sensory perception Sensory perception Olfactory lobe
development
Chromosome
segregation
Humoral immune
response mediated by
circulating
immunoglobulin
Activation of immune
response
GO:0019236 GO:0019236 GO:0030199 GO:0048285 GO:0072376 GO:0050778
Response to
pheromone
Response to
pheromone
Collagen fibril
organization
Organelle
fission
Protein activation
cascade
Positive regulation of
immune response
GO:0009263 GO:0007186 GO:0031589 GO:0051301 GO:0006956 GO:0048002
Deoxyribonucleotide
biosynthetic process
G-protein coupled
receptor signaling
pathway
Cell-substrate adhesion Cell division Complement activation Antigen processing and
presentation of peptide
antigen
GO:0007186 GO:0002861 GO:0071526 GO:0000278 GO:0002474 GO:0072376
G-protein coupled
receptor signaling
pathway
Regulation of
inflammatory
response to antigenic
stimulus
Semaphorin-plexin
signaling pathway
Mitotic cell
cycle
Antigen processing and
presentation of peptide
antigen via MCH class I
Protein activation
cascade
GO:0033108 GO:0002675 GO:0007155 GO:0007051 GO:0019882 GO:0006956
Mitochondrial
respiratory chain
complex assembly
Positive regulation of
acute inflammatory
response
Cell adhesion Spindle
organization
Antigen processing and
presentation
Complement activation
GO:0009262 GO:0050877 GO:0002040 GO:0031023 GO:0006958 GO:0002455
Deoxyribonucleotide
metabolic process
Neurological system
process
Sprouting angiogenesis Microtubule
organizing
center
organization
Complement activation
classical pathway
Humoral immune
response mediated by
circulating
immunoglobulin
GO:0006270 GO:0050715 GO:0090132 GO:0007052 GO:0002449 GO:0002684
DNA replication
initiation
Positive regulation of
cytokine secretion
Epithelial migration Mitotic spindle
organization
Lymphocyte mediated
immunity
Positive regulation of
immune system process
GO:0032981 GO:0046146 GO:0021772 GO:0051297 GO:0017144 GO:0002478
Mitochondrial
respiratory chain
complex I assembly
Tetrahydrobiopterin
metabolic process
Olfactory bulb
development
Centrosome
organization
Drug metabolic processes Antigen processing and
presentation of
exogenous peptide
antigen
DOWN-REGULATED
GO:0007265 GO:0051056 GO:0044364 GO:0008299 GO:0007067 GO:0007067
Ras protein signal
transduction
Regulation of small
GTPase mediated
signal transduction
Disruption of cells of
other organism
Isoprenoid
biosynthetic
process
Mitosis Mitosis
GO:0051056 GO:0007265 GO:0031640 NONE* GO:0000280 GO:0000280
Regulation of small
GTPase mediated
signal transduction
Ras protein signal
transduction
Killing of cells of other
organism
Nuclear division Nuclear division
GO:0046578 GO:0046578 GO:0051818 GO:0048285 GO:0048285
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Table 3 Developmentally regulated Gene Ontology groups for whole lung in WT and Scnn1b-Tg mice (Continued)
Regulation of Ras
protein signal
transduction
Regulation of Ras
protein signal
transduction
Disruption of cells of
other organism involved
in symbiotic interaction
Organelle fission Organelle fission
GO:0007266 GO:0007266 GO:0051883 GO:0007059 GO:0007059
Rho protein signal
transduction
Rho protein signal
transduction
Killing of cells in other
organism involved in
symbiotic interaction
Chromosome segregation Chromosome
segregation
GO:0035295 GO:0016568 GO:0006953 GO:0051301 GO:0051301
Tube development Chromatin
modification
Acute phase response Cell division Cell division
GO:0010631 GO:0016569 GO:0050829 GO:0006323 GO:0000278
Epithelial cell
migration
Covalent chromatin
modification
Defense response to
Gram-negative bacterium
DNA packaging Mitotic cell cycle
GO:0090130 GO:0016570 GO:0002886 GO:0000278 GO:0006323
Tissue migration Histone modification Regulation of myeloid
leukocyte mediated
immunity
Mitotic cell cycle DNA packaging
GO:0090132 GO:0007507 GO:0051873 GO:0000819 GO:0071103
Epithelium migration Heart development Killing by host of
symbiont cells
Sister chromatid
segregation
DNA conformation
change
GO:0060562 GO:0046777 GO:0051852 GO:0000070 GO:0022402
Epithelial tube
morphogenesis
Protein
autophosphorylation
Disruption by host of
symbiont cells
Mitotic sister chromatid
segregation
Cell cycle process
GO:0035239 GO:0072358 GO:0031424 GO:0071103 GO:0034470
Tube morphogenesis Cardiovascular system
development
Keratinization DNA conformation
change
ncRNA processing
Top ten developmentally up- and down-regulated Gene Ontology groups for whole lung in WT and Scnn1b-Tg mice between the specified developmental
intervals. Gene Ontology groups in common between the WT and Scnn1b-Tg line are highlighted by bolded and italicized text. Groups are only listed if FDR <0.1.
*NONE indicates that no additional groups met the significance threshold FDR<0.1.
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long-term consequences for lung health [37].
We next conducted analyses whereby the specific
genes and pathways altered by transgene expression at the
four time points were determined (Figure 2; Tables 3 and
4; Additional file 3: Table S1). Despite the robust patho-
logical findings consistently observed in Scnn1b-Tg mice
after PND 3 (neutrophilia, macrophage activation, airspace
enlargement, mucus plugging [9,12]), overexpression of
the Scnn1b transgene in the club cells produced surpris-
ingly few significant (FDR ≤ 0.05, FC ≥ 2) gene expression
changes as evaluated from whole lung RNA (Additional
file 2: Results file S1): only 84 combined DEGs (3, 2, 16,
and 72, at PND 0, 3, 10, and 42, respectively), were iden-
tified between Scnn1b-Tg and WTmice (Figure 2; Table 4).
As expected, the Scnn1b transgene was up-regulated at
all time-points (Table 4). A majority of DEGs were up-
regulated only at PND 42, with only a few genes (for ex-
ample: Scgb1c1, Cyp2a4, Fabp1) robustly down-regulated,
and very few genes differentially expressed at PND 0 and
PND 3 time points. The down-regulated group at PND 10
included genes (Muc5ac, Clca3, Slc26a4, and Chi3l4), asso-
ciated with Th2 inflammatory processes and mucous cell
functions, as described above (Tables 1 and Table 2).Since Scnn1b-Tg expression is driven by the promoter
for Scgb1a1 gene (encoding club cell secretory protein),
and because club cells are transiently necrotic during
early postnatal life [9], we looked specifically at Scgb1a1
gene expression as a surrogate for club cell function.
Levels of Scgb1a1 were modestly reduced in Scnn1b-tg
mice compared to WT at PND 0, 3 and 10 [fold-
change −1.9 (p-value 0.009), −1.7 (p-value 0.02), −1.5
(p-value 0.06), respectively], but not at PND 42 [fold-
change −1.04 (p-value 0.82)]. These data indicate that
normal club cell function was disrupted during early
post-natal life as a result of transgene expression, as
expected from histological findings, and that disruption of
club cell function may be contributing to early inflamma-
tory processes [38]. However, in the chronic state of
muco-obstruction observed at PND 42, club cell function
as measured by Scgb1a1 expression was normal.
Evaluation of Gene Ontology terms associated with
the differentially regulated genes was only moderately
informative, since the genes belonged to multiple anno-
tation categories that only rarely overlapped (Additional
file 3: Table S1). However, after a review of the literature,
most of the DEGs at PND 42, i.e., when chronic disease
is firmly established, fell into expected functional
Figure 2 Differential expression of genes in Scnn1b-Tg lungs
compared to WT. Unsupervised hierarchical clustering of the
combined set of DEGs that survive the filtering criteria (FDR ≤ 0.05,
fold-change ≥2) for WT versus Scnn1b-Tg for any time point; total
genes represented = 84 (Additional file 2: Results file S1). Dark blue
indicates lower expression levels and bright red indicates higher
expression levels and each column represents the results of one
microarray (n = 3 pools for each time point and genotype). DEGs
appearing more than once reflect alternative probeset annotations
on the Affymetrix microarrays. Scnn1b and Ttr differential gene
expression reflects the overexpression from the transgenic
construct used to generate the Scnn1b-Tg mice [9].
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tory processes (Itgb2, Kynu, Ptgir), neutrophil influx
(Bst1, Cd177, Cxcr1), activation of adaptive immunity
(Cd84, Ch25h, Gla, Il7r, Mmp19), dendritic cells (Itgax,
Ly75); macrophages (Bcl2a1, Ccl6, Ccl9, Cd68, Ctsk,Ch25h, Gpnmb, Hc, Lilrb4) or epithelial responses to
stimuli (Clca3, Ctsd, Gp2, Muc5ac, Pigr, Slc26a4). A
significant number of the DEGs were associated with
classic Th2 inflammatory responses (Ccl6, Chia, Chi3l4,
Clca3, Ear11, F7, Itgax, Slc26a4, Tbxas1) and alternative
(M2) macrophage polarization (Retnla, Arg1, Chi3l3,
Chi3l4, Ch25h, Lipa, Mgl2, Mmp12, Mrc1, Tbxas1)
(Table 4 and Additional file 3: Table S1).
Analyses of GSEA pathways differentially expressed
between WT and Scnn1b-Tg mice at the different time
points confirmed up-regulation of inflammatory responses
starting at PND 10 (Additional file 1: Figure S2; Additional
file 4: Results file S2; Additional file 5: Results file S3) and
revealed novel responses associated with the establish-
ment of obstructive lung disease, such as up-regulation
of GO cilia-specific pathways at PND 10, alterations in
tissue organization and development (pathways up-
regulated at PND 0 and down-regulated at PND 3) and
possible disturbances in the establishment of lung im-
mune homeostasis (pathways down-regulated at PND
0) (Table 5). By PND 42, there were no down-regulated
pathways that met the significance threshold.
Overall, these data suggest that defective airway mucus
clearance due to Scnn1b-Tg overexpression, although
originated in a relatively small compartment, i.e., the
airway epithelia, which comprises less than 2% of the
total lung surface area, can lead to transcriptional modi-
fications that affect other lung compartments and cell
populations, e.g., parenchymal and myeloid lineages,
which are strong enough to be detected in whole lung
preparations. However, the relative dearth of robust
gene-level signatures, especially at the earlier time
points, suggested that evaluating gene expression in
purified cell populations would be informative. Due to
the robust morphological activation of macrophages in
the Scnn1b-Tg mice, the tendency for genes involved in
macrophage function to be up-regulated in whole lung
(Additional file 3: Table S1), and the importance of this
cell type in lung disease pathogenesis, we continued
our studies by evaluating gene expression in purified
pulmonary macrophages.
Macrophage DEGs between Scnn1b-Tg and WT are robust
and dynamic
We hypothesized that defective mucus clearance would
alter lung macrophage gene expression and, consequently,
we studied purified BAL macrophages from WT and
Scnn1b-Tg mice at the previously utilized developmental
stages. Furthermore, to evaluate the contribution of lung
bacterial infections, the gene expression profiles of lung
macrophages purified from germ-free (GF) Scnn1b-Tg and
WT littermates at PND 42 were also studied. In addition
to macrophages, the harvested BAL preparations includes
lymphocytes, eosinophils, and neutrophils, with the
Table 4 Differentially expressed genes between WT and Scnn1b-Tg whole lungs
Gene
Name
PND 0 PND 3 PND 10 PND 42
Fold- Change FDR p-value Fold-Change FDR p-value Fold-Change FDR p-value Fold-Change FDR p-value
Scnn1b 11.7 8.47E-05 14.8 2.23E-05 14.0 3.10E-05 10.4 2.38E-05
Ttr 1.5 1.4 2.2 1.98E-02 1.8
9930013L23Rik 1.2 −1.2 −2.2 4.20E-02 1.2
Thbs2 −1.0 −1.1 −2.6 6.25E-05 1.1
Fabp1 −1.0 −1.1 −1.1 −2.1 3.69E-04
Chst4 1.1 1.0 1.1 −2.1 1.35E-04
Scgb1c1 −1.5 −1.2 −1.2 −2.3 4.87E-02
Cyp2a4 −1.0 1.1 1.1 −2.4 1.91E-02
Sult1d1 −1.1 −1.1 1.1 −2.8 9.46E-03
Chi3l4 −1.1 −1.1 −3.1 5.78E-02 30.1 5.77E-07
Clca3 −1.0 1.0 −5.8 6.25E-05 21.9 4.37E-08
Slc26a4 −1.1 −1.2 −2.0 4.26E-01 10.3 7.47E-05
Muc5ac 1.0 1.1 −2.6 1.23E-02 2.6 2.34E-03
Phxr4 2.2 3.64E-02 −1.0 −1.1 1.0
Gm22843 2.1 2.67E-02 1.0 1.0 −1.0
Abp1 (Aoc1) 1.2 2.8 2.41E-02 2.3 1.66E-02 1.1
Gpnmb 1.1 2.1 7.69E-01 5.5 5.45E-02 13.4 7.53E-04
Bst1 −1.0 1.4 2.8 2.02E-02 1.6
Sncg 1.1 −1.0 2.4 1.39E-02 1.2
Wdr16 −1.2 1.6 2.1 1.23E-02 1.2
Anxa8 −1.1 1.3 2.1 1.41E-02 1.1
Clu 1.1 1.4 2.1 1.40E-02 1.1
H19* −1.3 −1.0 2.6 1.46E-02 1.0
Mmp12 −1.0 −1.1 5.4 4.53E-03 34.8 2.96E-07
Cd177 −1.2 1.8 6.6 2.69E-02 11.3 1.52E-03
Ctsk 1.0 1.4 2.7 1.41E-02 9.5 1.19E-06
Pigr 1.1 1.5 2.3 2.92E-01 4.9 3.40E-03
Gp49a 1.1 1.2 2.3 4.63E-01 4.8 1.94E-02
Lilrb4 1.1 1.3 2.4 3.56E-01 4.2 1.82E-02
Ccl9 −1.2 1.0 2.0 5.04E-01 3.9 1.79E-02
Mcoln3 −1.0 1.1 2.0 1.67E-01 3.4 2.13E-03
Cd68 −1.1 1.3 2.1 1.14E-01 2.8 6.81E-03
Gp2 −1.0 −1.0 1.8 9.9 2.63E-04
Arg1 −1.2 −1.3 1.7 8.9 6.84E-03
BC048546 −1.1 1.1 1.8 7.5 7.47E-05
Ear11 −1.1 1.0 −1.5 7.2 4.73E-06
Awat1 1.0 1.0 1.0 6.6 3.59E-03
Ch25h −1.0 −1.2 1.4 6.2 1.30E-04
Chi3l3 1.1 1.3 −1.5 5.8 9.46E-03
Cxcr1 1.0 −1.0 1.2 5.7 9.66E-04
Bcl2a1d −1.2 −1.1 −1.3 5.4 1.91E-02
Retnla (Fizz1) −1.4 −1.2 −1.9 5.0 4.84E-02
Itgax −1.1 −1.3 1.6 4.4 4.59E-03
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Table 4 Differentially expressed genes between WT and Scnn1b-Tg whole lungs (Continued)
Igk-V1 −1.0 −1.2 1.0 3.9 2.64E-02
Fbp1 −1.2 −1.1 −1.4 3.8 8.44E-05
Chia −1.1 −1.2 −1.3 3.5 9.69E-03
Ccl6 −1.0 1.3 1.2 3.5 4.13E-02
Ly75 1.0 −1.1 1.6 3.3 7.53E-04
Ighv8-12 1.1 −1.1 −1.1 3.2 1.62E-06
Tm4sf19 1.0 1.0 1.1 3.2 3.91E-05
Slc39a2 1.1 −1.1 1.7 3.2 3.42E-02
Kynu 1.0 1.2 1.1 3.0 5.52E-03
Ms4a8a −1.0 −1.0 1.3 3.0 4.18E-04
Reg3g −1.3 1.7 1.7 3.0 4.08E-02
Csf2rb −1.1 1.3 1.9 3.0 2.08E-02
Mgl2 −1.0 −1.0 −1.6 2.9 4.19E-04
Slc7a2 −1.1 1.2 1.1 2.9 9.46E-03
Cd84 −1.1 −1.0 1.4 2.9 1.53E-03
F7 −1.2 1.3 1.7 2.9 1.94E-02
Gla −1.2 1.4 1.3 2.7 7.90E-03
Itgb2 −1.3 1.1 1.7 2.7 1.66E-02
Mmp19 −1.0 1.3 1.1 2.6 3.25E-02
Tbxas1 −1.3 1.1 1.2 2.6 2.76E-03
Lrp12 −1.1 −1.1 1.2 2.6 2.38E-05
Bcl2a1a 1.1 −1.1 1.2 2.6 1.27E-02
Slc6a20a 1.1 −1.0 1.2 2.5 6.17E-03
Cd200r4 −1.1 −1.0 1.5 2.5 1.52E-03
Rbp4 −1.4 −1.1 −1.0 2.4 1.94E-02
Lipa −1.3 1.1 1.1 2.4 5.62E-04
Bcl2a1b 1.1 −1.0 1.2 2.4 2.06E-02
Il7r −1.0 1.0 1.5 2.4 3.71E-02
Fn1 −1.0 −1.2 −1.4 2.3 4.24E-02
Mrc1 −1.0 1.1 1.1 2.3 1.14E-02
Ctsd −1.1 1.2 1.4 2.3 4.87E-04
Hc 1.1 −1.1 −1.3 2.1 1.94E-02
Ptgir −1.0 1.1 −1.1 2.1 1.91E-02
Lilra5 1.0 −1.2 1.1 2.1 3.40E-03
Dhcr7 −1.1 −1.1 1.1 2.1 2.55E-02
Tnfrsf26 −1.0 1.0 1.2 2.1 1.29E-02
Fnip2 1.1 1.4 1.2 2.1 1.33E-02
Acp5 −1.0 1.0 1.7 2.1 9.46E-03
Myo5a 1.1 −1.2 1.0 2.0 2.85E-02
Syk −1.0 1.1 1.2 2.0 1.68E-02
Fetub −1.1 1.3 1.5 2.0 3.92E-02
Differentially expressed (fold-change >2; FDR<0.05) genes between WT versus Scnn1b-Tg from whole lung. Genes are listed if they were significant at one or more
of the four developmental stages measured. Fold-change represents Scnn1b-Tg:WT. Up-regulated and down-regulated fold-changes are highlighted bold and
italics, respectively.
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Table 5 Differentially regulated Gene Ontology groups from whole lung between WT and Scnn1b-Tg mice
PND 0 PND 3 PND 10 PND 42
UP-REGULATED
GO:0031424 NONE* GO:0006953 GO:0006954
Keratinization Acute-phase response Inflammatory response
GO:0035195 GO:0002526 GO:0050715
Gene silencing by miRNA Acute inflammatory response Positive regulation of cytokine
secretion
GO:0090505 GO:0050707 GO:0001816
Epiboly involved in wound healing Regulation of cytokine secretion Cytokine production
GO:0090504 GO:0003341 GO:0050663
Epiboly Cilium movement Cytokine secretion
GO:0035194 GO:0050715 GO:0002444
Posttranscriptional gene silencing by RNA Positive regulation of cytokine
secretion
Myeloid leukocyte mediated
immunity
GO:0044319 GO:0006954 GO:0002274
Wound healing, spreading of cells Inflammatory response Myeloid leukocyte activation
GO:0035278 GO:0045087 GO:0050707
Negative regulation of translation involved in gene
silencing by miRNA
Innate immune response Regulation of cytokine
secretion
GO:0045974 GO:0032640 GO:0043299
Regulation of translation, ncRNA-mediated Tumor necrosis factor production Leukocyte degranulation
GO:0035313 GO:0002886 GO:0006955
Wound healing, spreading of epidermal cells Regulation of myeloid leukocyte
mediated immunity
Immune response
GO:0040033 GO:0044782 GO:0050729
Negative regulation of translation, ncRNA-mediated Cilium organization Positive regulation of
inflammatory response
DOWN-REGULATED
GO:0048002 GO:0007059 GO:0043931 NONE*
Antigen processing and presentation of peptide
antigen
Chromosome
segregation
Ossification involved in bone
maturation
GO:0009410 GO:0007067 GO:0061298
Response to xenobiotic stimulus Mitosis Retina vasculature development in
camera-type eye
GO:0006805 GO:0000280 GO:0060039
Xenobiotic metabolic process Nuclear division Pericardium development
GO:0002495 GO:0048285 GO:0070977
Antigen processing and presentation of peptide
antigen via MHC class II
Organelle fission Bone maturation
GO:0071466 GO:0051301 GO:0002067
Cellular response to xenobiotic stimulus Cell division Glandular epithelial cell
differentiation
GO:0002367 GO:0071103 GO:0030198
Cytokine production involved in immune response DNA conformation
change
Extracellular matrix organization
GO:0002374 GO:0006260 GO:0043062
Cytokine secretion involved in immune response DNA replication Extracellular structure organization
GO:0002478 GO:0006261 GO:0097435
Fibril organization
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Figure 3 Gene expression patterns in purified BAL macrophages. (a) PCA plot as in Figure 1a for purified macrophages from WT (Squares)
and Scnn1b-Tg (Triangles) mice at PNDs 0 (red), 3 (green), 10 (blue), 42 (purple) and for germ-free (GF) macrophages at PND 42 (orange). PC#1
(22% of the overall variance) separates the PND 0 from other ages; PC#2 (6.6% of the overall variance) separates WT from Scnn1b-Tg. (b) Unsupervised
hierarchical clustering of the combined set of developmentally regulated DEGs as determined for Figure 1b except from purified macrophages (total
number of genes represented = 4763; Additional file 2: Results file S1). (c) Unsupervised hierarchical clustering of the combined set of DEGs in
macrophages filtered as in Figure 2 for WT versus Scnn1b-Tg (total genes represented = 1320; Additional file 2: Results file S1). For this figure, symbols,
color coding and filtering were as in Figure 1. GF = germ-free.
Table 5 Differentially regulated Gene Ontology groups from whole lung between WT and Scnn1b-Tg mice (Continued)
Antigen processing and presentation of exogenous
peptide antigen
DNA-dependent DNA
replication
GO:0034381 GO:0051297 GO:0007044
Plasma lipoprotein particle clearance Centrosome
organization
Cell-substrate junction assembly
GO:0097006 GO:0000278 GO:0050919
Regulation of plasma lipoprotein particle levels Mitotic cell cycle Negative chemotaxis
Top ten differentially up- and down-regulated Gene Ontology groups from whole lung between WT and Scnn1b-Tg mice at the four developmental stages.
Groups are only listed if FDR <0.1.
NONE indicates that no groups reached the significance threshold (FDR<0.1).
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Scnn1b-Tg and among developmental time points. To
minimize granulocytes proportions in the BAL, macro-
phages were purified by negative selection for Ly6G ex-
pression (a marker exclusively expressed on neutrophils
and eosinophils), and pools with 95.86% ± 0.25% (SEM)
purity were obtained (Additional file 1: Figure S3 and
Additional file 3: Table S2). Lack of Ly-6G expression in
all macrophage preparations used in this study was con-
firmed by gene array data (data not shown).Table 6 Developmentally regulated genes in purified macrop
Gene
Name
Fold-change: PND 3 vs 0 Gene
Name
Fold-chan
WT Scnn1b-Tg WT
UP-REGULATED
Fabp1 42.2 8.6 Ear11 39.5
Coro6 24.3 3.0 Fbp1 18.0
Treml4 24.1 13.2 Ccl24 12.2
Rnase6 14.1 6.0 Retnlg 12.0
F630028O10Rik* 13.5 12.3 Retnla 9.8
Gm4070 10.8 4.7 Ccl17 9.4
AW112010 10.6 13.9 Alox15 4.3
Mcoln3 9.4 18.6 Arg1 4.1
Gbgt1 8.6 8.3 Prg2 3.6
Irg1 8.5 118.2 Ch25h 3.3
Alox5 8.5 4.1 H2-Ab1 3.1
2010016I18Rik 8.4 6.5 H2-Aa 3.0
Rab44 8.3 3.1 Il13 3.0
Cfb 8.3 11.4 Mmp12 3.0
Fpr1 8.0 15.5 Serpine1 2.9
DOWN-REGULATED
Agr2 −223.2 −171.4 Hp −10.4
Chad −105.2 −163.4 Scgb1a1 −9.7
Muc5b −83.9 −113.5 Saa3 −8.6
Meg3* −65.4 −84.1 Irg1 −7.8
Lypd2 −64.7 −83.5 Scgb3a1 −6.7
Muc16 −63.4 −83.4 Reg3g −6.3
Gp2 −60.9 −92.3 Xist* −6.2
Krt7 −60.1 −51.7 Clec4e −5.4
Atp1b1 −58.6 −56.7 Slc4a1 −5.3
Igf2 −57.4 −78.0 Rsad2 −5.1
H19* −57.3 −137.5 Mmp14 −4.8
Msln −54.2 −7.1 BC100530 −4.7
Clic3 −53.7 −5.9 Alas2 −4.1
AU021092 −52.9 −5.7 Gm5416 −4.0
BC048546 −52.9 −5.7 Gypa −4.0
Top 15 developmentally up- and down-regulated genes from purified macrophage
top 15 genes are shown for both WT and Scnn1b-Tg mice.PCA analysis of purified macrophage arrays showed
both age and genotype as drivers of global gene expression
variation (Figure 3a). PC1 separated macrophages at PND
0 from later time points. However, PC2 separated macro-
phages from Scnn1b-Tg and WT mice at PND 3, PND 10,
and PND 42, indicating disease-specific activation of
gene signatures. PND 0 WT and Scnn1b-Tg macro-
phages separated primarily in PC5, with other PCs
reflecting either age or other unexplained variation
(Additional file 1: Figure S1b). Interestingly, macrophageshages from WT mice
ge: PND 10 vs 3 Gene
Name
Fold-change: PND 42 vs 10
Scnn1b-Tg WT Scnn1b-Tg
10.5 Spag11b 23.8 21.0
3.8 Cpne5 18.7 7.0
4.6 Slc9a2 10.2 2.5
−2.1 Lrg1 7.4 3.1
1.0 Pnpla5 6.5 2.0
5.0 Ucp3 6.4 5.8
1.9 Epcam 6.2 1.5
−1.8 Gca 5.4 3.1
1.4 5730507C01Rik 5.4 3.5
3.9 D630039A03Rik 5.3 6.2
2.2 Gm26154* 4.8 1.5
2.0 Cd74 4.8 5.9
1.4 Gal 4.8 2.1
1.9 H2-Ab1 4.7 5.8
1.6 Tnfsf13b 4.6 −1.1
−5.4 Ear11 −44.3 14.0
−4.1 Fbp1 −19.1 15.8
−51.9 S100a9 −16.8 −3.0
−6.3 Arg1 −14.3 2.4
−8.2 Retnlg −14.0 1.6
−10.5 Retnla −13.7 10.6
−9.8 Ccl24 −12.6 3.8
−1.7 Mmp12 −10.1 −1.2
−4.6 AA467197 −7.6 1.0
−3.5 AB124611 −6.3 −2.9
−1.8 Ldhb −6.0 −5.1
−3.1 Tarm1 −5.9 −1.5
−3.1 Itgam −5.8 −2.4
−36.8 Ebi3 −5.8 −4.6
−3.2 Alox15 −5.6 3.5
s of WT mice between three separate age intervals. The fold-changes for these
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age-matched SPF counterparts.
As with the whole lung, the population of macrophages
purified from the BAL exhibited robust developmental
patterns, evident at all time points (Tables 6, 7 and 8).
Evaluation of the top-signaling genes generated a com-
plex picture with a number of obvious differences be-
tween WT and Scnn1b-Tg mice, especially noticeable at
the PND 42 versus PND 10 interval, where genes down-
regulated in WT mice were up-regulated in Scnn1b-Tg
mice (Table 6) and vice versa (Table 7). The especiallyTable 7 Developmentally regulated genes in purified macrop
Gene
Name
Fold change: PND 3 vs 0 Gene
Name
Fold cha
Scnn1b-Tg WT Scnn1b-
UP-REGULATED
Irg1 118.2 8.5 Ear11 10.5
Saa3 55.5 5.5 Fabp1 6.7
Clec4e 52.9 8.0 Ccl17 5.0
Gpr84 40.7 3.5 Ccl24 4.6
Inhba 39.3 1.8 Coro6 4.3
Gm5416 32.3 −1.6 Ch25h 3.9
Il1f9 32.2 3.6 Sorbs3 3.8
Cxcl3 26.2 1.9 Fbp1 3.8
Slc11a1 23.2 2.2 Sftpc 3.2
Pla2g7 23.1 4.3 Ear5 3.2
Ccrl2 21.5 4.6 Map1b 3.1
Mcoln3 18.6 9.4 Ffar4 3.0
Aoah 18.3 3.9 Pdk4 2.9
Slc7a11 17.6 5.3 Htr2c 2.9
Cxcl1 17.0 1.1 Mamdc2 2.9
DOWN-REGULATED
Agr2 −171.4 −223.2 Stfa3 −60.6
Chad −163.4 −105.2 Saa3 −51.9
H19* −137.5 −57.3 Lcn2 −48.9
Tcf21 −129.7 −36.3 Gm5416 −36.8
Fmo2 −119.6 −36.6 BC100530 −27.9
Muc5b −113.5 −83.9 Stfa2 −24.4
AU021092 −92.4 −52.9 Chi3l1 −20.0
Gp2 −92.3 −60.9 Stfa2l1 −19.0
Meg3* −84.1 −65.4 S100a9 −18.9
Lypd2 −83.5 −64.7 Olfm4 −15.5
Muc16 −83.4 −63.4 Asprv1 −13.8
Igf2 −78.0 −57.4 Prok2 −12.3
Acta1 −76.7 −2.0 Thbs1 −12.2
Fhl1 −72.2 −21.6 Il1r2 −12.0
BC048546 −71.2 −52.9 Ifitm1 −11.2
Top 15 developmentally up- and down-regulated genes from purified macrophage
these top 15 genes are shown for both Scnn1b-Tg and WT mice.robust differential gene expression between the PND 0
and PND 3 time point (Figure 3b; Additional file 2: Results
file S1) is consistent with previous studies identifying this
interval as a key interval for alveolar macrophage differen-
tiation [39]. Robust up-regulation of Siglec5 and Itgax
(also known as SiglecF and Cd11c; fold-change 7.7 and
5.0, and FDR 1.0E-10 and 2.7E-9, respectively) between
PND 0 and PND 3, which then stabilized between
all other intervals (fold changes < 1.5; FDR >0.3; not
shown), confirmed the previous observations that these
cell surface markers appear suddenly and that theyhages from Scnn1b-Tg mice
nge: PND 10 vs 3 Gene
Name
Fold change: PND 42 vs 10
Tg WT Scnn1b-Tg WT
39.5 Rbp4 69.2 −1.8
2.4 Spag11b 21.0 23.8
9.4 Fbp1 15.8 −19.1
12.2 Ear11 14.0 −44.3
1.8 Awat1 13.4 −3.4
3.3 Bex1 12.8 −1.5
2.4 Retnla 10.6 −13.7
18.0 Sox7 10.0 −1.1
1.0 Lhx2 9.5 −1.2
2.4 Scgb1a1 8.5 3.2
−1.1 Slc1a2 7.8 1.0
1.8 Arnt2 7.2 1.0
1.6 Cpne5 7.0 18.7
2.2 Scd1 6.9 1.6
1.4 Ear5 6.8 −1.0
−2.8 BC100530 −9.0 −3.9
−8.6 Mmp14 −7.9 −1.5
−3.8 Nt5e −7.9 −1.3
−4.0 Hp −7.6 −1.3
−4.7 Stfa2l1 −6.5 −2.9
−2.6 Irg1 −6.2 1.0
−1.7 Spink2 −5.9 −5.0
−2.8 Clec4e −5.8 2.0
−1.8 Cxcl2 −5.8 −1.9
−1.5 Apoc2 −5.3 −2.9
−1.8 Apoe −5.2 −3.8
−1.1 Ldhb −5.1 −6.0
−1.8 Hilpda −5.0 −1.2
−1.4 Lpcat2 −4.9 −1.6
−1.7 Sftpc −4.8 −1.6
s of Scnn1b-Tg mice between three separate age intervals. The fold-changes for
Table 8 Developmentally regulated Gene Ontology groups in purified macrophages from WT and Scnn1b-Tg mice
PND 3 vs PND 0 PND 10 vs PND 3 PND 42 vs PND 10
WT Scnn1b-Tg WT Scnn1b-Tg WT Scnn1b-Tg
UP-REGULATED
GO:0007059
Chromosome
segregation
GO:0019882 Antigen
processing and presentation
NONE* NONE* GO:0007157 Heterophilic
cell-cell adhesion
GO:0032944 Regulation
of mononuclear cell
proliferation
GO:0000070
Mitotic sister
chromatid
segregation
GO:0007059 Chromosome
segregation
NONE* GO:0070663 Regulation
of leukocyte
proliferation
GO:0000819 Sister
chromatid
segregation
GO:0048002 Antigen
processing and presentation of
peptide antigen
GO:0050670 Regulation
of lymphocyte
proliferation
GO:0006310 DNA
recombination
GO:0071346 Cellular response
to interferon-gamma
GO:0045058 T cell
selection
GO:0006302
Double-strand
break repair
GO:0032615 Interleukin-12
production
GO:0050870 Positive
regulation of T cell
activation
GO:0007067
Mitosis
GO:0032655 Regulation of
interleukin-12 production
GO:0042129 Regulation
of T cell proliferation
GO:0006281 DNA
repair
GO:0045087 Innate immune
response
GO:0006720 Isoprenoid
metabolic process
GO:0048285
Organelle fission
GO:0002474 Antigen
processing and presentation of
peptide antigen via MHC class
I
GO:0051251 Positive
regulation of
lymphocyte activation
GO:0000280
Nuclear division
GO:0032606 Type I interferon
production
GO:0048002 Antigen
processing and
presentation of peptide
antigen
GO:0000725
Recombinational
repair
GO:0032479 Regulation of type
I interferon production
GO:0070661 Leukocyte
proliferation
DOWN-REGULATED
GO:0060541
Respiratory
system
development
GO:0060485 Mesenchyme
development
GO:0035456
Response to
interferon-beta
GO:0030595 Leukocyte
chemotaxis
GO:0007059
Chromosome
segregation
GO:0007067 Mitosis
GO:0030324
Lung
development
GO:0030324 Lung
development
GO:0035458
Cellular response
to interferon-beta
GO:0050900 Leukocyte
migration
GO:0007067 Mitosis GO:0000280 Nuclear
division
GO:0030323
Respiratory tube
development
GO0030323 Respiratory tube
development
GO:0045087
Innate immune
response
GO:0045087 Innate
immune response
GO:0000280 Nuclear
division
GO:0007059
Chromosome
segregation
GO:0060485
Mesenchyme
development
GO:0060541 Respiratory
system development
GO:0045851 pH
reduction
GO:0006954
Inflammatory response
GO:0048285 Organelle
fission
GO:0048285 Organelle
fission
GO:0002009
Morphogenesis of
an epithelium
GO:0001657 Ureteric bud
development
GO:0051607
Defense
response to virus
GO:0006955 Immune
response
GO:0000070 Mitotic
sister chromatid
segregation
GO:0000819 Sister
chromatid segregation
GO:0048762
Mesenchymal cell
differentiation
GO:0055123 Digestive system
development
GO:0051453
Regulation of
intracellular pH
GO:0060326 Cell
chemotaxis
GO:0000819 Sister
chromatid segregation
GO:0033700
Phospholipid efflux
GO:0048729
Tissue
morphogenesis
GO:0048762 Mesenchymal
cell differentiation
GO:0051452
Intracellular pH
reduction
GO:0048520 Positive
regulation of behavior
GO:0000278 Mitotic cell
cycle
GO:0000070 Mitotic
sister chromatid
segregation
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Table 8 Developmentally regulated Gene Ontology groups in purified macrophages from WT and Scnn1b-Tg mice
(Continued)
GO:0003007 Heart
morphogenesis
GO:0048562 Embryonic
organ morphogenesis
GO:0048525
Negative
regulation of viral
process
GO:0032103 Positive
regulation of response
to external stimulus
GO:0000725
Recombinational repair
GO:0007052 Mitotic
spindle organization
GO:0048562
Embryonic organ
morphogenesis
GO:0048565 Digestive tract
development
GO:0030641
Regulation of
cellular pH
GO:0002690 Positive
regulation of
leukocyte chemotaxis
GO:0007052 Mitotic
spindle organization
GO:0070301 Cellular
response to hydrogen
peroxide
GO:0010632
Regulation of
epithelial cell
migration
GO:2000736 Regulation of
stem cell differentiation
GO:0002224 Toll-
like receptor
signaling
pathway
GO:0002687 Positive
regulation of
leukocyte migration
GO:0000724 Double-
strand break repair via
homologous
recombination
GO:0090068 Positive
regulation of cell cycle
process
Top ten developmentally up- and down-regulated Gene Ontology groups for purified macrophages in WT and Scnn1b-Tg mice between the specified
developmental intervals. Gene Ontology groups in common between the WT and Scnn1b-Tg line are highlighted by bolded and italicized text. Groups are only
listed if FDR <0.1.
*NONE indicates that no groups met the significance threshold (FDR<0.1).
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mediately after birth in mice [39]. This dataset may be
especially useful to identify transcriptional changes that
accompany Siglec5 and Itgax up-regulation during this
critical time.
GSEA pathways analysis was more informative than
gene-level data to establish the overall trends (Table 8
Additional file 1 Figure S4). In the PND 0–3 interval,
WT macrophages exhibited up-regulation of GO path-
ways involved in cell growth and differentiation, and, inter-
estingly, up-regulation of pathways in WT mice at the later
two intervals was minimal. Down-regulated signals during
the PND 0–3 interval suggest that these early post-natal
macrophages have the ability to respond to signals that
are directing normal lung development and differenti-
ation. We cannot rule out the possibility that the
macrophage preparations contain a small percentage of
epithelial cells, which would confound interpretation.
However, epithelial cell contamination was not obvious
histologically (data not shown). The strength of down-
regulated signals in macrophages for GO lung and
respiratory development pathways (Table 8) during this
interval suggest that lung epithelium and macrophages
use similar signals to coordinate differentiation between
the two tissues. Down-regulation of the cell proliferation
pathways occurring in the WT and Scnn1b-Tg mice at
the PND 10–42 period are consistent with the estab-
lishment of long-lived, slow proliferating pulmonary
macrophage populations during steady state [39,40].
Significant down-regulation of GO innate immune re-
sponse pathways in both lines during the PND 3–10
interval points toward the steady-state, mature pul-
monary macrophage as relatively quiescent and tolerant
toward low danger stimuli. Finally, unlike WT macro-
phages, Scnn1b-Tg macrophages exhibited up-regulation
of pathways involved in innate immune responses as
expected from their morphologically activated state,
with the GSEA signatures being especially robustbetween the PND 10 and PND 42 (Table 8). Further
exploration by directly comparing gene expression
between WT and Scnn1b-Tg macrophages provided
additional insights.
As expected from the PCA, DEGs were identified
between WT and Scnn1b-Tg macrophages at each time
point evaluated, with 432, 394, 166, and 437 DEGs at
PND 0, 3, 10, and 42, respectively, using the established
significance threshold (FC ≥ 2; FDR ≤ 0.05) (Figure 3c;
Additional file 2: Results file S1). As expected from the
previous discussion, the top-signaling genes vary across
time and represent a variety of biological processes
(Table 9). The most significant GO pathways up-
regulated by disease at PND 0 are related to muscle cell
gene expression, which is difficult to reconcile with the
known literature on pulmonary macrophages. However,
by PND 3 and onward, significant up-regulation of a
variety of inflammatory signatures was observed in the
Scnn1b-Tg mice compared to WT mice (Table 10). The
down-regulation of GO pathways related to mitosis in
Scnn1b-Tg mice at the earlier time points (PND 3 and
PND 10) indicate that Scnn1b-Tg pulmonary macro-
phages are less prolific than their WT counterparts at
these early post-natal ages, a shift that is likely a
response to the altered cytokine milieu that develops in
the Scnn1b-Tg mice as a response to the signals that are
arising from the bacterial infections and/or necrotic club
cells at these time points.
Custom-annotated pathways allow assessment of
disease-specific features
The previously described GSEA analysis, based on publi-
cally available GO pathway annotations, provided evidence
for activation of relevant biological pathways in both lung
and macrophages during the development of disease.
However, due to incomplete annotation, GO pathways
are not expected to capture all processes specifically
associated with lung biology and pulmonary diseases.
Table 9 Differentially regulated genes between purified macrophages from Scnn1b-Tg and WT mice
PND 0 PND 3 PND 10 PND 42
Gene
Name
Fold-
Change
FDR p-
value
Gene
Name
Fold-
Change
FDR p-
value
Gene
Name
Fold-
Change
FDR p-
value
Gene
Name
Fold-
Change
FDR p-
value
UP-REGULATED
Acta1 43.4 9.12E-16 Lcn2 42.6 4.11E-05 Inhba 25.8 1.04E-05 Ear11 137.8 4.70E-06
Tnnc2 37.9 4.27E-15 Stfa3 35.2 1.70E-05 Mmp14 22.3 1.14E-06 Fstl1 85.4 6.63E-12
Csn1s2a 32.6 2.11E-06 Gm5416 32.0 4.46E-05 Irg1 17.1 9.85E-05 Rbp4 70.5 3.57E-09
Tg 25.9 3.53E-03 Thbs1 27.3 6.67E-06 Npy 15.3 4.18E-05 Fbp1 67.1 2.23E-05
Csn2 23.4 5.58E-05 Stfa2 26.4 9.55E-05 H2-M2 14.0 1.58E-09 Mfge8 52.0 1.38E-11
Mylpf 22.7 1.19E-07 Chi3l1 20.6 8.07E-06 Slc11a1 12.8 5.51E-06 Awat1 51.9 3.74E-08
Scnn1b 21.5 2.01E-03 Saa3 20.2 2.00E-04 Clec4e 12.3 5.88E-06 Arg1 42.7 1.17E-05
Wap 19.5 7.79E-04 Inhba 20.1 1.74E-05 Cxcl2 11.9 2.64E-06 Inhba 36.8 5.26E-07
Slc4a1 17.8 8.38E-03 Cxcl1 15.8 2.63E-06 Pmp22 11.0 1.20E-03 Mmp12 33.9 7.64E-09
Glycam1 17.7 3.44E-04 Stfa2l1 15.8 2.75E-03 Ass1 10.9 2.25E-05 Retnla 33.8 3.12E-04
Car3 16.1 1.90E-03 Prok2 14.3 4.83E-11 Hp 10.3 7.72E-06 Ppap2b 27.8 3.32E-12
Rsad2 16.0 2.29E-03 Plbd1 14.0 4.65E-05 Mfge8 10.0 1.22E-06 H2-M2 25.0 6.63E-12
Csn1s1 15.9 1.70E-03 Irg1 13.9 1.09E-04 Cxcl3 9.7 2.62E-04 Ccl24 24.2 1.07E-03
Tnnt3 15.2 1.58E-08 Gm10872* 13.9 7.19E-04 Cxcl16 9.2 2.64E-06 Bex1 18.9 2.04E-08
Gypa 14.0 9.23E-03 Cxcl3 13.6 2.25E-05 Pla2g7 8.4 3.15E-04 AA467197 17.4 2.17E-07
DOWN-REGULATED
Gm10473 −3.8 5.41E-03 Coro6 −6.1 4.47E-04 Cidec −2.7 1.07E-02 Epcam −5.2 4.79E-06
Gm24049* −3.6 2.14E-02 Hpgd −5.1 4.44E-04 Rab44 −2.7 4.02E-04 Gal −5.1 6.71E-04
6720489N17Rik −3.3 2.23E-02 Fabp1 −5.1 3.16E-04 G0s2 −2.6 1.33E-02 Tnfsf13b −4.8 6.04E-11
Lilra5 −2.9 5.01E-04 Flt1 −3.6 8.97E-06 Fam212a −2.6 4.99E-03 Dnahc11 −4.5 2.76E-08
1600002K03Rik −2.9 3.39E-02 Kazald1 −3.4 2.10E-03 Gm5936 −2.5 2.25E-02 Kazald1 −4.0 3.85E-04
Snora74a* −2.8 4.99E-02 Gpr34 −2.9 6.50E-04 Prr5l −2.5 3.11E-02 Nt5e −4.0 5.80E-05
Snora73b* −2.8 1.02E-02 Slc6a4 −2.9 3.94E-04 Tmem150b −2.4 9.43E-03 Cpne5 −3.9 4.10E-04
Gdf15 −2.7 3.36E-03 Gm1966 −2.9 4.65E-05 Csf3r −2.4 2.37E-02 Slc9a2 −3.8 1.03E-05
Vgf −2.7 3.30E-02 Fam212a −2.8 7.44E-04 Cd2 −2.4 4.82E-03 Fam212a −3.7 2.91E-05
2010005H15Rik −2.7 3.73E-02 Cd2 −2.8 3.54E-04 Klk8 −2.4 1.20E-02 Egfem1 −3.7 9.82E-05
Aqp11 −2.7 9.12E-03 Klk8 −2.8 9.32E-04 Kcnh4 −2.3 1.19E-02 Gpr141 −3.7 2.18E-03
P2ry13 −2.6 7.04E-03 Gm11545 −2.8 1.37E-02 Sec14l2 −2.2 7.39E-03 Itgad −3.5 1.23E-05
F630111L10Rik* −2.6 1.26E-02 Rnase6 −2.8 1.17E-02 Gm12258 −2.2 2.18E-02 Iqgap2 −3.4 5.72E-06
Ch25h −2.6 2.26E-02 Trp53i11 −2.8 2.74E-02 Gsg2 −2.1 4.20E-03 Pnpla5 −3.3 6.36E-06
Krt6a −2.6 3.37E-04 Cidec −2.7 6.13E-03 Arhgef39 −2.0 1.36E-02 Grap2 −3.3 7.52E-04
Differentially expressed up- and down-regulated (fold-change >2; FDR <0.05) genes between Scnn1b-Tg and WT mice from purified macrophages at the four
developmental times. Fold-changes are Scnn1b-Tg:WT.
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vided utilizing custom pathway annotations created to
query known, disease-relevant processes. To query our
gene expression data for transcriptional events associated
with specific pathologic features of the Scnn1b-Tg model,
customized gene lists were generated that reflected genes
hypothesized or known to be involved in the pathogenesis
of muco-obstructive lung diseases (Additional file 4:
Results file S2 and Additional file 5: Results file S3). Custom
pathways were developed either from compilation ofliterature, e.g., M1 polarized versus M2 polarized path-
ways, or by selecting genes known to be regulated under
specific experimental conditions (e.g., allergen exposure,
hypoxia, endoplasmic reticulum stress, autophagy, apop-
tosis) or cell-specific markers (macrophage activation, cili-
ated cells, mucous cell, inflammatory cell subsets, secreted
antimicrobials) (Figure 4a; Additional file 4: Results file
S2). A further group of pathways representing a number
of disease-relevant gene expression signatures from hu-
man studies as defined by Chowdhary et. al. [41] were
Table 10 Differentially regulated Gene Ontology groups from purified macrophages between WT and Scnn1b-Tg mice
PND 0 PND 3 PND 10 PND 42 PND 42 Germ-free
UP-REGULATED
GO:0006936 GO:0030595 GO:0072593 GO:0009611 GO:0006954
Muscle contraction Leukocyte chemotaxis Reactive oxygen species
metabolic process
Response to wounding Inflammatory response
GO:0003012 GO:0032103 GO:0030595 GO:0032103 GO:0009611
Muscle system process Positive regulation of
response to external stimulus
Leukocyte chemotaxis Positive regulation of
response to external
stimulus
Response to wounding
GO:0003007 GO:0060326 GO:0060326 GO:0030595 GO:0030595
Heart morphogenesis Cell chemotaxis Cell chemotaxis Leukocyte chemotaxis Leukocyte chemotaxis
GO:005500 GO:0050900 GO:0060445 GO:0006954 GO:0032103
Striated muscle cell
development
Leukocyte migration Branching involved in salivary
gland morphogenesis
Inflammatory response Positive regulation of
response to external
stimulus
GO:0060537 GO:0006935 GO:2000379 GO:0071621 GO:0071345
Muscle tissue
development
Chemotaxis Positive regulation of reactive
oxygen species metabolic
process
Granulocyte chemotaxis Cellular response to
cytokine stimulus
GO:0055001 GO:0071621 GO:0032103 GO:0002687 GO:0034097
Muscle cell development Granulocyte chemotaxis Positive regulation of response
to external stimulus
Positive regulation of
leukocyte migration
Response to cytokine
stimulus
GO:0043062 GO:0002687 GO:2000147 GO:0002685 GO:0042330
Extracellular structure
organization
Positive regulation of
leukocyte migration
Positive regulation of cell
motility
Regulation of leukocyte
migration
Taxis
GO:0051216 GO:0042330 GO:0050921 GO:0002253 GO:0050714
Cartilage development Taxis Positive regulation of chemotaxis Activation of immune
response
Positive regulation of
protein secretion
GO:0031032 GO:0050795 GO:2000377 GO:0002757 GO:0006935
Actomyosin structure
organization
Regulation of behavior Regulation of reactive oxygen
species metabolic process
Immune response-
activating signal
transduction
Chemotaxis
GO:0030239 GO:0048520 GO:0002690 GO:0042330 GO:0002685
Myofibril assembly Positive regulation of
behavior
Positive regulation of leukocyte
chemotaxis
Taxis Regulation of leukocyte
migration
DOWN-REGULATED
GO:0007186 GO:0006996 GO:0007059 NONE* NONE*
G-protein coupled
receptor signaling
pathway
Organelle organization Chromosome segregation
GO:0034470 GO:0007059 GO:0000819
ncRNA processing Chromosome segregation Sister chromatid segregation
GO:0006364 GO:0000819 GO:0000070
rRNA processing Sister chromatid segregation Mitotic sister chromatid
segregation
GO:0016072 GO:0006261 GO:0032465
rRNA metabolic process DNA-dependent DNA
replication
Regulation of cytokinesis
GO:0034660 GO:0006302 GO:0006281
ncRNA metabolic process Double-strand break repair DNA repair
GO:0042254 GO:0000070 GO:0032508
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Table 10 Differentially regulated Gene Ontology groups from purified macrophages between WT and Scnn1b-Tg mice
(Continued)
Ribosome biogenesis Mitotic sister chromatid
segregation
DNA duplex unwinding
GO:0045076 GO:0007051 GO:0051983
Regulation of interleukin-
2 biosynthetic process
Spindle organization Regulation of chromosome
segregation
GO:0008033 GO:0051225 GO:0007051
tRNA processing Spindle assembly Spindle organization
NONE* GO:0008608 GO:0000280
Attachment of spindle
microtubules to kinetochore
Nuclear division
GO:0000724 GO:0007067
Double-strand break repair via
homologous recombination
Mitosis
Top ten differentially up- and down-regulated Gene Ontology groups from purified macrophages between WT and Scnn1b-Tg mice at the four developmental
stages. Groups are only listed if FDR <0.1.
*NONE indicates that no groups or no additional groups met the significance threshold (FDR <0.1).
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S2). Literature and database references, as well as de-
tails related to the selection of genes in these pathways,
are provided (Additional file 5: Results file S3 and
Additional file 5: Results file S3 references).
Using these custom annotations, significant GSEA
disease-relevant signatures were identified that were
tissue/cell specific and time-dependent (Figure 4). In
macrophages, substantial evidence for polarization into
both M1 and M2 phenotypes was detected. With respect
to whole lung, a previously unappreciated up-regulation
of ciliated cell- and dendritic cell-specific genes in
Scnn1b-Tg was identified at PND 3–10 and PND 42,
respectively. Mucous cell signatures were consistently
found in whole lung at PND 42 that correlated with
the expression of epithelial genes previously reported
to be induced by SAM-pointed domain–containing
Ets-like factor (Spdef ), a transcriptional regulator of
mucous cell differentiation in mouse and humans [43].
Gene signatures for mucus production were consistent
with previous reports [12]. Interestingly, strong up-
regulation of Spdef-associated genes was also observed
in macrophages at each time point. A mucous cell
signature in PND 3 whole lungs, which correlated with
up-regulation of genes normally suppressed by Spdef
over-expression, was also detected, suggesting a time-
dependent activation of alternative pathways. The gene
expression pattern of whole lung for secreted antimicro-
bials correlated with the location and timing of spontan-
eous infection in Scnn1b-Tg mice. Signatures for hypoxia
and protease/anti-protease activation were more variable
across tissues and time points and more difficult to
interpret.
Importantly for the use of this model in the context
of human disease, strong up-regulation of human lungdisease-specific signatures, including those for chronic
obstructive pulmonary disease, were observed in both
the lungs (PND 10–42) and macrophages (PND 3–42)
(Figure 4b). Specifically, the positive association of
DEGs in this study with human DEG disease signatures
is seen at the later time points (PND 10 and PND 42).
These two time points reflect the establishment and
maintenance of the chronic lung disease state in this
model. Thus, it is not surprising that they reflect the
human tissue better than the earlier time points, since
human disease signatures are derived from tissue of
patients with established disease, and for the most part,
except for BPD, they reflect diseases development that
occurs in already mature human lungs.
Evidence for time-dependent M1 and M2 polarization in
Scnn1b-Tg macrophages
Because of our interest in the state of pulmonary macro-
phages in response to disease development, the expres-
sion of M1 and M2 markers (Additional file 6: Results
file S4) compiled after extensive literature review [44-47]
was carefully examined, and the results summarized in
heatmaps (Figure 5). The heatmaps highlight the dynamic
nature of the macrophage response to airway surface de-
hydration/defective mucus clearance. Enrichment of both
M1 and M2 pathways was evident in PND 3 macrophages,
but M1 signatures were particularly robust at PND 3 and
M2 signatures particularly robust at PND 42. The M1
signature, while still evident, was clearly different at PND
42 compared to earlier time points, with increased expres-
sion of some genes (e.g., Cxcr1 and Cd69) and decreased
expression of others genes (e.g., Nos2 and Cxcl2) com-
pared to PND 3. Similarly, some M2 markers were exclu-
sively high at PND 3 (e.g., Chi3l1, Il10 and Mmp9), and
others at PND 42 (e.g., Retnla, Chi3l4, Mrc1, Ccl17, Ccl24,
Figure 4 GSEA using custom gene sets. (a) Custom gene sets representing putatively relevant processes were used for GSEA (Additional file 4:
Results file S2). The FDR values were converted into enrichment scores for clustering by the formula, score = 0.1 – (0.9 *FDR). Red and green
indicated up- and down- regulation, respectively. Genes in the custom sets and their sources are described in Additional file 5: Results file S3.
(b) Heat-map as described in (a) for “Respiratory Disease” pathways [41] and COPD-specific pathways [42].
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Cd80, Ccl3 and Socs3) and M2 (e.g., Arg1, Mmp12 and
Trem2) markers were consistently up-regulated during
PND 3–42 interval (Figure 5a). The M1 and M2 signatures
were also identified globally in whole lung (Figure 5b). The
enrichment in M2 markers at PND 42 was confirmed
by evaluating protein levels of Retnla (Fizz1), Chi3l3
(YM1), and Chi3l4 (YM2) in BAL extracts (Additional
file 1: Figure S5).
This activation pattern is consistent with the presence
of necrotic cells and bacteria in the lungs of the Scnn1b-Tg
mice at PND 3 and the requirement for macrophages to
participate in their clearance via up-regulation of Th1
(M1) responses. Because Th1 responses are known to
inhibit Th2 responses [48,49], including mucous cell
metaplastic responses, we hypothesize that the robustTh1 (M1) responses at PND 3 and 10 dampen the Th2-
skewed environment normally seen in early post-natal
lung development identified in this study and described
elsewhere [50]. The shift to M2 polarization after PND
10 reflects the more chronic nature of lung disease,
featuring mucus accumulation, but no overt bacterial
colonization and normal club cell morphology and func-
tion (no necrotic cells). M2 macrophages are known to be
critical for defense against atypical fungal and helminth
infections [51,52], and an increase in M2-like alveolar
macrophages is characteristic of many inflammatory lung
diseases in both humans and mice [20], but the reason for
the shift to M2 in our model is not clear. We hypothesize
that this (phenomenon) is directly related to the presence
of dehydrated mucus with trapped endogenous and
exogenous noxious particles and the ability of the
ab
Figure 5 M1 and M2 DEG signatures in Scnn1b-Tg macrophages and whole lung. Heat-maps from normalized expression values of M1 and
M2 macrophage-activation-related genes (see gene list in Additional file 6: Results file S4 under headings “Macrophage M1 Activation” and
“Macrophage M2 Activation”) in purified macrophages (Panel a) and whole lung (Panel b). Higher and lower expression is represented by red
and blue, respectively; with each individual heat-map produced separately (each heat-map has its own unique range of values indicated by dark
blue to bright red). The corresponding data can be found in Additional file 6: Results file S4. Each column represents data from one array (n = 3
for lung; n = 4 for other macrophage groups for each genotype), with WT or Scnn1b-Tg (Tg) status listed above the columns. Each row represents
a single gene.
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the airways. This shift to M2 clearly is expected to have
profound consequences, since it is not the normal state in
health, and extended long-term activation of M2macrophages is associated with the establishment of
chronic lung disease [53]. Future studies should focus on
defining the signals within mucus plugs that drive M2
polarization.
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with separate groups of genes activated at different time
points, also likely reflects the intrinsic variety of the pul-
monary macrophage population [20]. Our sampling tech-
nique did not allow a distinction between macrophages
residing in localized niches within the lung. Besides the
obvious distinction between conducting airway and alveo-
lar spaces, we postulate the existence of several sub-niches
where local signals regulate local macrophage phenotypes.
These would include areas of localized hypoxia, infections,
necrotic/apoptotic cell death, aspiration, and mucus plug-
ging, with the frequency and importance of each of these
niches shifting across development [54,55].
Whole lung and macrophages produce independent
inflammatory signals
To further explore the inflammatory signals originating
from, or possibly leading to, the M1 and M2 polarization
patterns, the “cytokine production” node within Gene
Ontology Biological Process was scrutinized (Figure 6a).
At PND 0, the only signs of activation of this node were
in macrophages (Figure 6b; Additional file 3: Table S3;
Additional file 1: Figure S6; Additional file 7: Results
file S5). Genes in this GO node were not activated in
whole lung until PND 10 with signals increasing fur-
ther at PND 42 (Figure 6b; Additional file 3: Table S3).
While this analysis shows robust activation of the GOFigure 6 Dynamics of inflammatory phenotype in the Scnn1b-Tg mou
children nodes of the “Cytokine Production” node of the Gene Ontology b
(boxes) according to the hierarchy of GO terms, and visualized in Cytoscap
the GO annotation. Only functional GO terms containing at least 3 annotat
GO node in Scnn1b-Tg mice in the two tissues studied across time. Red ind
with annotated genes up-regulated in the Scnn1b-Tg mice with the intens
annotated genes to up-regulation (darker = more significant), as reflected b
genes to down-regulation in the Scnn1b-Tg mice compared to WT as detenode related to Scnn1b-Tg expression, careful gene-level
evaluation of these signatures revealed that they were pri-
marily derived from either whole lung, e.g., Cxcl5, Chia,
and Ltf, or macrophages (many), with only a few genes
producing signal from both tissues, e.g., Ccl3, Chi3l1, and
Tnfrsf9 (Additional file 3: Table S3). Overall, macrophages
exhibited more robust signals than whole lung, with both
up-regulated and a small number of down-regulated genes
identified. Because we had seen activation of a number of
macrophage markers in whole lung (Additional file 3:
Table S1), we hypothesized that much of the signal
detected from whole lung originated from the activated
macrophage population. However, it is clear from our data
(Additional file 3: Table S3) that for most DEGs, the epi-
thelial/parenchymal compartment and the macrophages
uniquely contribute to the inflammatory signaling in re-
sponse to airway mucus obstruction. Within each tissue,
as for the M1 and M2 genes (Figure 5), DEGs tended to
differ across time, e.g., genes robustly signaling in macro-
phages at PND 0, which were enriched for KEGG “pancre-
atic cancer” pathways containing Tgfb2 (not shown), were
substantially different than those signaling at PND 3
(enriched for KEGG pathways containing Il6 and Tnf such
as those involved in NOD-like and Toll-like receptor
signaling), and those signaling at PND 42 (enriched for
KEGG pathway “chemokine signaling” containing Ccr7,
Ccr5, and Arrb1). While a detailed analysis of all of these as represented by cytokine production GO node. (a) The
iological process were arranged as clusters of connected entities
e. Each box represents a GO term and associated genes as defined by
ed genes were included. (b) Activation of the “Cytokine Production”
icates the nodes within this GO cluster that are significantly enriched
ity of the color reflecting the significance of the collective shifts of
y GSEA FDR values. Green represents collective shifts of annotated
rmined by GSEA.
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beyond the scope of this publication, this study provides
a framework for future efforts directed at individual sig-
naling molecules and further highlights the usefulness
of this model for a variety of pulmonary disease research
questions.
Scnn1b-Tg macrophage gene signatures were comparable
but more robust in GF vs. SPF environment
GF macrophages from either WT or Scnn1b-Tg mice
were very similar compared to their SPF counterpartsa
b
Figure 7 Gene expression patterns in germ-free (GF) macrophages co
Unsupervised hierarchical clustering of the small set of DEGs that are eithe
(shown on left) or between SPF and GF Scnn1b-Tg macrophages (shown o
Each column represents expression from a single microarray (n = 3 for GF;
Figure 2. GSEA analyses for custom gene-set (b) and multiple immune syst
GF WT macrophages (left column) or SPF versus GF Scnn1b-Tg macrophag
Figure 4. The corresponding data can be found in Additional file 8: Results(Figure 3c), and only 32 genes were differentially
expressed across the four groups at the selected signifi-
cance threshold (Figure 7a). This result is significant
because it demonstrates that macrophage activation, at
least in the chronic disease state present at PND 42, is not
dependent upon the presence of microbes or microbe-
derived products, consistent with our previous discussion.
By extension, macrophage activation at this stage must be
in response to the consequence of epithelial transgene
overexpression, namely, airway surface dehydration and
the resultant mucus stasis. The gene expression findingsc
mpared to specific-pathogen free (SPF) environments. (a)
r differentially expressed between SPF and GF WT macrophages
n right) purified from PND 42. Gene symbols are shown to the right.
n = 4 for SPF). Filtering for DEGs and colors are as described as in
em pathway (c) and Gene Ontology annotations comparing SPF versus
es (right column). Color coding and significance parameters were as in
file S6.
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Scnn1b-Tg colony [13] and reinforce our hypothesis that,
if airway surfaces are dehydrated, static mucus itself
and/or abiotic materials concentrated in dehydrated
mucus, trigger and maintain lung inflammation and
airway remodeling.
While the differential gene expression in the GF mac-
rophages was qualitatively similar between the GF and
SPF Scnn1b-Tg macrophages (Figure 3; Additional file 1:
Figure S7a), the quantitative fold-change was higher in
GF compared to SPF Scnn1b-Tg mice, and GSEA analysis
showed a more robust up-regulation of custom gene set
(Figure 7b; Additional file 1: Figure S7a) and multiple im-
mune system (Figure 7c) pathways in macrophages from
GF compared to SPF Scnn1b-Tg mice (Additional file 8:
Results file S6). We speculate that the absence of environ-
mental bacteria and their products altered the homeostatic
mechanisms that normally prevent excessive activation of
resident macrophages, predisposing GF mice to exagger-
ated responses to external challenges, including airway
surface dehydration (Additional file 1: Figure S7b). These
findings are congruent with excessive activation as a key
feature of gut inflammatory responses in mice raised
in germ-free conditions and they highlight the role of
endogenous microflora in establishment of immune
homeostasis in the lung as well [56].
Conclusion
The gene expression analyses reported here provide a
global appreciation for the complexity of the development
of lung disease in the Scnn1b-Tg model. Importantly, the
initiating stimulus in the model, i.e., mucus dehydration,
is present during early postnatal life, allowing unique
investigations into the relationships between a defined dis-
ease stimulus (airway surface dehydration) and postnatal
lung development. This feature, which leads to emphy-
sema, provides a setting to study the pathogenic crosstalk
between mucus obstructed and inflamed airways and
alveoli, processes that are likely important in children with
BPD, CF, and COPD-like pediatric diseases. The Th1 air-
way inflammation produced as part of the “insult” trans-
mitted from the airways to the alveolar compartments is a
likely culprit in the Scnn1b-Tg mice. Our studies also
reveal macrophages as early responders to airway mucus
stasis and as possible communicators of inflammatory
signals from the airways to the alveoli.
In contrast, the gene expression changes identified
during the chronic stage of disease are more reflective of
typical adult onset muco-obstructive lung diseases.
Moving forward, separating the two phase of disease
will be necessary to define pathogenic mechanisms.
The complexity of gene signatures additionally point to-
ward the necessity of considering cell-specific, and even
site-specific, signals in future studies. Further evaluationof cell-specific lineages, including those of airway epithe-
lial cells and macrophages purified from different lung
compartments (e.g., airways vs alveolar, mucus embedded
vs free), will be invaluable to generate an integrated pic-
ture of the pathways leading to lung disease in this model
and likely inform translational therapeutic efforts.
Availability of supporting data
Data Repository: Please use the following URL in order
to access our private GEO database. “http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE47551”.
Additional Supporting Data Files: This file summarizes
the information about supplemental files associated with
the manuscript titled: “Gene Expression in Whole Lung
and Pulmonary Macrophages Reflects the Dynamic
Pathology Associated with Airway Surface Dehydration”.
Additional files
Additional file 1: Figure S1. Principal component analysis (PCA). PCA
of gene expression from WT and Scnn1b-Tg whole lung and purified BAL
macrophages. Figure S2. Lung Gene Set Enrichment Analysis (GSEA).
Heatmap representing top level GO and more stringent GSEA enrichment
signals in whole lung between WT and Scnn1b-Tg mice at the four times
studied. To fit the result into a legible figure, only top level (1 and 2 levels
down from the root vocabulary term) GO biological processes and more
stringent enrichment score were used as a functional annotation for this
figure (Additional file 4: Results file S2). Results were considered significant
when FDR < 1%. The FDR values were converted into enrichment scores by
the formula: score = 0.01 – (0.9 * FDR). Red and green indicate up- and
down- regulation, respectively. Figure S3. Macrophage Purification.
Representative images showing (a) freshly isolated, unprocessed cells from
BALF, (b) purified Ly6G-negative macrophages, and (c) Ly6G positive cells
after removal of the Ly6G negative cells shown in (b). Figure S4. GSEA from
purified macrophages. Heatmap representing top level GO signals in
macrophages between WT and Scnn1b-Tg mice at the four times
studied (Additional file 4: Results file S2). Details of the analysis are provided
in legend to Additional file 5: Figure S2. Figure S5. Western blot analyses
for M2 macrophage activation markers (Chi3l3, Chi3l4 and Retnla) on protein
extracts from purified macrophages from PND 42 WT and Scnn1b-Tg mice.
Figure S6. Heat-map of fold changes between Scnn1b-Tg and WT mice
across tissues of expressed genes (Additional file 7: Results file S5) in the
“Cytokine Production” GO node, whose mean log2 intensities are greater
than 5 in at least one sample group in whole lung or macrophages.
Figure S7. M1 and M2 macrophage-activation gene signatures in germ-free
(GF) and specific pathogen free (SPF) mice.
Additional file 2: Results file S1. This excel file contains tables of log2
normalized intensity values for named genes used to generate hierarchical
clustering heat-maps in figures indicated by the name of the tables. The
original excel file for further analyses will be made available in the
supplementary section. To generate the heat-maps, choose one of the
3 gene identifier columns, e.g. “gene symbol” and save the spreadsheet
table as tab-delimited text file as input to any software tool designed to
clustering microarray data. “Lung_Fig1b_time_cluster” worksheet (for
Figure 1b), “Lung_Fig2_BvsWT_cluster” worksheet (for Figure 2),
“MAC_Fig3b_time_cluster” worksheet (for Figure 3b), “MAC_-
Fig3c_BvsWT_cluster” worksheet (for Figure 3c).
Additional file 3: Table S1. Functional and Gene Ontology Terms
associated with the differentially expressed genes between Scnn1b-Tg
and WT whole lung as outlined in Table 3. Functional categories are
based upon author annotations from a literature review. Table S2.
Percent Cell Counts (Percentage) on Purified Macrophage Fractions.
Table S3. Top cytokine signaling gene level table corresponding to the
“Cytokine Signaling” Gene Ontology pathway results for differential gene
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http://www.biomedcentral.com/1471-2164/15/726expression in whole lung and macrophages comparing Scnn1b-Tg mice
to WT at the time points indicated. Genes are grouped into categories
based upon the characteristics defined in the headings. Genes are only
shown if the fold-change was ±2-fold for any condition. Light red indicates
up-regulation in Scnn1b-Tg compared to WT. Green indicates down-regulation.
Additional file 4: Results file S2. This excel file contains tables of
converted enrichment significance score from GSEA results for clustering
analysis. The names of the individual worksheets indicate corresponding
figures (Figure 4a and b; Figures S2 and S4) that show the clusters based
on the specific data. For each table, GSEA results from relevant individual
comparisons were extracted using a specified FDR cutoff, T (e.g. 0.1 or
0.01) in at least one of the comparisons. The pooled FDR values (F) were
then converted to the enrichment score (S) by the following formula:
S = T – (0.9 * F) contained in these tables for clustering.
Additional file 5: Results file S3. This excel file containing custom
gene sets using in the GSEA analysis described in the manuscript. The
supporting files containing literature reference can be found in
Additional file 5: Results file S3 References. The format is in .gmt as
documented by GSEA (http://www.broadinstitute.org/gsea/). To use them
in GSEA analysis, export the table from Excel as tab-delimited text file,
then rename the text file with .txt extension to .gmt file, and use as GSEA
input according to GSEA user guide.
Additional file 6: Results file S4. This excel file containing expression
values of M1 and M2 custom gene set in macrophages and whole lung
that were used to generate Figure 5 and Additional file 1: Figure S7.
Additional file 7: Results file S5. This excel file contains data tables for
Figure 6. For each comparison between Scnn1b-Tg vs WT, GSEA
enrichment summary tables (consult http://www.broadinstitute.org/gsea/
documentation for output format) GO biological process terms branching
off from “Cytokine production” were copied into each spreadsheet table
as indicated in the table name. To regenerate the results, GO terms were
displayed as connected networks by Cytoscape (http://www.cytoscape.
org/) and the FDR values were used to convert to enrichment scores
described above, from each GSEA summary table saved as tab-delimited
text files were used to decorate the GO term nodes as color intensities.
The fold change values for “Cytokine production” genes were filtered at
minimal of 1.5 fold change between Scnn1b-Tg and WT mice for at least
1 time point, then used for clustering in Additional file 1: Figure S6 are in
“CytoGene_fold_change_1.5” worksheet.
Additional file 8: Results file S6. This excel file contains log2
normalized intensity values of genes in macrophages from GF and SPF
conditions. This data was used to generate Figure 7.
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